In this episode of Daily Value, we look at how extra virgin olive oil and its polyphenols—including hydroxytyrosol—could impact your health and longevity. Referencing evidence from the Moli-Sani Study and other meta-analyses (PMID: 38704428), we uncover how these bioactives are suggested to reduce risks for cancer, cardiovascular disease, and all-cause mortality.

Discussion Points:

• Bioactive Compounds: How hydroxytyrosol prevents LDL oxidation and reduces inflammation, key mechanisms for cardiovascular protection.
• Landmark Studies: The Moli-Sani cohort found a 28% reduction in cancer deaths with a certain threshold of olive oil, while meta-analyses confirm a 16% lower cardiovascular risk with similar amounts of olive oil.
• Practical Takeaways: Why cold-pressed extra virgin olive oil is essential for these benefits and how just 3 tablespoons daily could support health outcomes.

https://pubmed.ncbi.nlm.nih.gov/38704428/